Vesicants pharmacology

Hurst, C.G., Smith, W.J. (2008). Health effects of exposure to vesicant agents. In Chemical Warfare Agents, Chemistry, Pharmacology, Toxicology, and Therapeutics (J. Romano, Jr., B. Lukey, H. Salem, eds), pp. 293-312. CRC Press, Boca Raton, FL. 

The mouse ear vesicant model has been used to evaluate pharmacological agents for countering SM dermal injury. The SM-induced skin injury in mouse ear was found to be... 

Dorr RT. Pharmacologic management of vesicant chemotherapy extravasations. In Dorr RT, Von Hoff DD, eds. Cancer Chemotherapy Handbook, 2nd ed. Stamford, Appleton Lange, 1994 109-118. 

Smith, M.G., Stone, W, Guo, R-E, et al., 2008. Vesicants and oxidative stress. In Romano Jr., J.A., Lukey, B.J., Salem, H. (Eds.), Chemical Warfare Agents Chemistry, Pharmacology, Toxicology, and Therapeutics, second ed. CRC Press/Taylor Francis Group, LLC, Boca Raton, FL, pp. 247-292. 

Arroyo CM and Janny SJ (1995) EPR/Spin label technique as an analytical tool for determining the resistance of reactive topical skin protectant (rTSPs) to the breakthrough of vesicant agents. Journal of Pharmacological and Toxicological Methods 33 109-112. 

---